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ABSTRACT 
Objective: Nonsyndromic orofacial clefts (NSOFCs) constitute about 70% of all orofacial clefts 
(OFCs) and present with no additional congenital disorder. NSOFCs have multifactorial etiology 
where genetic factors, environmental exposure, gene-environment interactions, stochastic 
factors and gene-gene interactions or epistasis may play cardinal roles. Moreover, NSOFCs 
largely do not follow Mendelian pattern of inheritance, warranting the need to investigate other 
genetic phenomena such as parent-of-origin (PoO) effects.  PoO effects investigate how 
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parental origin of alleles differentially impacts the phenotype of the offspring. The aim of this 
study was to identify genome-wide PoO effects that can increase risk for NSOFCs in humans. 
Patients and Method: The samples (174 case-parent trios from Ghana, Ethiopia and Nigeria) 
included in this study were from the African only GWAS study that was published in 2019. 
Genotyping of individual DNA using over 2 million multiethnic and African ancestry-specific 
SNPs from the Illumina Multi-Ethnic Genotyping Array (MEGA) v2 15070954 A2 (genome build 
GRCh37/hg19) was done at the Center for Inherited Diseases Research (CIDR). After quality 
control checks, PLINK was employed to carry out PoO analysis employing the pooled 
subphenotypes of NSOFCs. 
Results: We did not observe any genome-wide significant association (p < 5×10-8) in our study 
cohort. However, we observed possible hints of PoO effects at several interesting loci in the 
human genome.  These include a 1 mega base pair window at the major histocompatibility 
complex class 1 (MHC1) window on chromosome 6, ASB18, ANKEF1, AGAP1,  GABRD, 
HHAT, CCT7, DNMT3A, EPHA7,  FOXO3, long intergenic noncoding RNAs, microRNA, 
antisense RNAs and a few genes that encode proteins zinc finger DNA-binding motifs, such as 
ZNRD1, ZFAT and ZBTB16. 
Conclusion: Findings from our study suggest that some loci may increase the risk for NSOFCs 
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Orofacial clefts (OFCs) are the most common congenital craniofacial anomalies and the second 
most common structural birth defects after congenital heart defects (Modell and Mossey, 2012; 
Huang et al., 2019; van Rooij et al., 2019). These craniofacial birth defects have life-long 
financial and psychosocial repercussions on affected individuals, families, society and 
healthcare system. These conditions also affect dentition, speech, language, esthetics, feeding 
and social integration; and may require multiple surgeries and multidisciplinary team to manage 
(Nidey et al., 2016; Nidey and Wehby 2019). OFCs are usually grouped into cleft lip only (CL), 
cleft palate only (CPO) and cleft lip and palate (CLP), with about 50% of CPO being syndromic 
whereas about 70% of CL and CLP cases are nonsyndromic and present with no additional 
congenital malformation aside the cleft (Carlson et al., 2019). As a complex trait with 
multifactorial etiology, environmental exposure, genetic factors such as epistasis and parent-of-
origin effects, as well as gene-environment interactions may all contribute to the pathogenesis 
of OFCs (Thomas, 2010; Wei et al., 2014; Haaland et al., 2017; Gjerdevik et al., 2017). This 
suggests that maternal peri-conception exposure and intrauterine environment may interact with 
maternal genetic factors to increase susceptibility to NSOFCs in the fetus.  
Classical association studies are based on the premise that phenotypic effects of genetic 
variants do not depend on parental origin. Association studies are thus severely underpowered 
to detect non-Mendelian effects that may also influence phenotypes that emanate from genetic 
variants. This notwithstanding, an interesting non-Mendelian genetic phenomenon that has 
been postulated to probably play a role in the genetic etiology of OFCs is parent-of-origin (PoO) 
effects. PoO effects are epigenetic phenomena where the phenotypic consequences of genetics 
variants or alleles depend on whether they are inherited from the father or mother of an 
individual (Haaland et al., 2017; Gjerdevik et al., 2017; Zeng et al., 2019). The cardinal 
epigenetic phenomenon that usually manifest as PoO effects is genomic imprinting. Genomic 
imprinting is when two alleles at a given locus exhibit varied phenotypic effects that is not due to 
variation in DNA nucleotide sequence but emanate from epigenetic events (Lawson et al., 2013; 
Peters, 2014). Recently, a study (Zeng et al., 2019) demonstrated that PoO effects in humans 
may impact on DNA methylation patterns as well as their proximal and distant regulators, which 
may inadvertently impact on complex trait phenomics. Some complex genetic syndromes that 
may present with oral and craniofacial malformations, such as Angelman syndrome, Beckwith-
Wiedemann syndrome and Prader-Willi syndrome, have been shown to result from genomic 
imprinting events that manifest in PoO dependent manner (Lawson et al., 2013). 
Several genetic studies on OFCs have attempted to tease out PoO effects, howbeit, with varied 
outcomes. The studies reviewed here were carried out in populations of Asian and European 
ancestries, with data on population of African ancestry conspicuously lacking. A study that 
employed genome-wide association analysis of over 2,000 OFC case parent trios observed no 
genome-wide level significant PoO effects on risk of orofacial clefting (Shi et al., 2012). Other 
studies have demonstrated the probability of PoO effects, largely with increased maternal over-
transmission, increasing the risk to NSOFCs. DMD, FGF13, EGFL6 and Xp22.2 have been 
shown to increase the risk to NSOFCs through PoO effects with either maternal or paternal 
over-transmission in a study that analyzed SNPs on the X-chromosome for PoO effects (Skare 
et al., 2018). Other studies have also demonstrated parent-of-origin effects with excess 
maternal transmission in a few genes or loci that influence the risk of NSOFCs. These maternal 
PoO effects include genes such as RUNX2 gene (Sull et al., 2008), BCL3 (Park et al., 2009), 
TGFα (Sull et al., 2009a), PDGF-C (Wu et al., 2012), VAX1 (Butali et al., 2013), as well as 
PAX7 and PAX3 (Sull et al., 2009b). Some studies could not replicate the maternal PoO effects 
in RUNX2 (Jung et al., 2014), MTHFR (Boyles et al., 2008), ROR2 (Wang et al., 2012), TGFβ1 
(Raju et al., 2017) and LOXL3 (Khan et al., 2018). Interestingly, only few studies have 
demonstrated PoO effects with paternal over-transmission, including TGFβ3 (Reutter et al., 
2008) and MSX1 (Suazo et al., 2010).  A common observation for all these PoO effects analysis 
is the specificity of the association signals regarding ethnicity and cleft subphenotypes. Since 
data from populations of African ancestry is conspicuously missing and an opportunity for 
discovery in this ancestral population is possible, we conducted PoO effects studies in our 
African GWAS samples from Ghana, Ethiopia and Nigeria (Butali et al., 2019). We performed 
our PoO analysis using PLINK and observed several novel and potential PoO effects in our 
study cohort. 
 
MATERIALS AND METHODS 
Study population and ethics approval  
We had earlier published the characteristics of the study population, the genotyping platform 
used as well as the quality control criteria employed for data cleaning (Butali et al., 2019, Oseni 
et al., 2018). In summary, we recruited case parent trios from Ghana, Ethiopia and Nigeria; 
these included individuals born to Ghanaian, Ethiopian and Nigerian parents. No Caucasian or 
Asian case families were included in this study. The study was reviewed and approved by 
various institutional review boards: Kwame Nkrumah University of Science and Technology 
(CHRPE/RC/018/13), Addis Ababa University (003/10/surg), Lagos University Teaching 
Hospital (ADM/DCST/HREC/VOL.XV/321), Obafemi Awolowo University Teaching Hospital 
(ERC/2011/12/01) and the NIH Office of Human Subjects Research (OHSRP 11631). Cheek 
swab and saliva samples were collected from various centers in Africa and shipped to the Butali 
Lab at the University of Iowa for DNA extraction, quantification and XY-genotyping as a quality 
control step to verify the sexes of participants.  
 
Genotyping protocol and quality control 
A total of 25 μl of each DNA sample at a concentration of ≥50 ng/μl was shipped to the Center 
for Inherited Disease Research (CIDR) for Multi-Ethnic Genotyping Array (MEGA) genotyping 
employing the expanded Illumina MEGA v2 15070954 A2 (genome build GRCh37/hg19). The 
genotyping platform contained over 2 million multi-ethnic SNPs as well as about 60,000 rare 
variants that were specifically identified in populations of African ancestry. A total of 174 case-
parents trios were successfully genotyped (Table 1), including HapMap controls (70 unique 
samples and 9 duplicates) for quality control purposes. The detailed quality control (QC) 
processes had been published earlier (Oseni et al., 2018; Butali et al., 2019). The QC included 
establishment of continental ancestry with respect to HapMap samples, Hardy-Weinberg 
equilibrium test, confirmation of relatedness, identification of large chromosomal anomalies, sex 
chromosome anomalies, missing call rates and batch effects. The cleaned data was deposited 
in the database of genotypes and phenotypes (dbGaP) with accession ID phs001090.v1.p1. 
  
Parent-of-origin analysis 
The parent-of-origin (PoO) effects analysis was performed using PLINK (Purcell et al., 2007) 
which separately considered the transmission of allele from heterozygous fathers versus 
heterozygous mothers to affected offsprings. Thus, the PLINK PoO analysis investigated the 
effect of a risk variant based on whether it was inherited from the mother or the father. This 
PLINK PoO analysis is a modification of the traditional family-based transmission disequilibrium 
test (TDT) which does not separately consider transmissions from heterozygous mothers versus 
heterozygous fathers. The outcomes of PLINK PoO analysis include both paternal and maternal 
p-values resulting from paternal Chi-squared test and maternal Chi-squared test respectively. 
The PLINK PoO analysis also returns asymptotic overall p-values of parent-of-origin tests for 
difference in paternal versus maternal odds ratios.  
We applied PoO analysis on data consisting of 2,036,060 variants and obtained 1,062,324 
SNPs with valid parent-of-origin tests. Sequel to this, all SNPs with both paternal and maternal 
p-values less than 0.05 were removed, as these SNPs did not depict PoO effects. This cut-off 
point resulted in 64,109 SNPs, of which 20,258 had overall p-values less than 0.05. We did not 
carry out separate PoO effects analysis for each of the NSOFC subphenotypes due to the 
limited number of case-parent trios employed in this study (Table 1). We did not correct for 
multiple testing in our analysis though separate p-values were generated for mothers and 
fathers, as well as the overall p-value, because these three tests are not true independent tests. 
For example, Bonferroni correction and multiple different or less conservative methods could 
have been employed in our analyses to correct for the effect of multiple testing. However, 
utilizing the false discovery rate (FDR) resulted in all adjusted p-values being 1 due to there 
being so many SNPs. In order to ascertain whether a given SNP was located within or near a 
gene, SNPs were viewed in UCSC genome browser (www.genome.ucsc.edu) in a 100 kb 
genomic region around the SNP in question. The nearest gene to the SNP was presumed to be 
the tagging gene. All SNPs that were not located within or near a gene within the 100 kb window 
were classified as intergenic. To confirm the probable gene implicated by the UCSC genome 
browser, we searched for topologically associated domains (TADs) for each genomic locus by 
visualizing in the human reference genome (hg19) the interaction domain for the index SNP ID 
in 880kb genomic window (http://promoter.bx.psu.edu/hi-c/view.php).  
 
RESULTS 
Deciphering parent-of-origin effects  
Though this study was a genome-wide scan for PoO effects, none of the p-values observed 
reached genome-wide significant value of 5.0×10-8. This notwithstanding, we observed very 
interesting trends towards genome-wide significant level which suggest subtle hints of possible 
PoO effects in our NSOFCs cohort from Ghana, Ethiopia and Nigeria. SNPs which were 
significant for either maternal (P_MAT) or paternal (P_PAT) p-values, as well as overall PoO p-
values (P_POO), were considered as exhibiting possible PoO effects. This was to determine 
which parent was transmitting the allele differently or contributing mostly to the overall parent-of-
origin p-value. A total of 12,156 SNPs exhibited both P_MAT or P_PAT < 0.05, and P_POO < 
0.05; however, we report here SNPs with overall p-values of ≤2.32 × 10-3 (Table 2). The table 
also contains the Z-score which shows the number of standard deviations a given data point lies 
from the mean. It is known that in most large data sets, about 99% of the values have Z-scores 
ranging from -3 to 3. This suggests that the p-values lie within three standard deviations above 
and below the mean. The z-scores scores observed in Table 2 demonstrate the quality of the 
data used for our analyses, as all the z-scores were within -3 to 3. 
 
The SNP that exhibited the highest PoO effect (P_POO = 5.12 × 10-4) was rs57792200. This 
SNP showed paternal over-transmission PoO effect (P_PAT = 6.58 × 10-4) and is located within 
an intron of ankyrin repeat and SOCS [suppressor of cytokine signaling] box containing 18 
(ASB18) gene. Apart from ASB18 gene, other genes with ankyrin repeat motif, including 
ANKEF1 (rs6057132) and AGAP1 (rs4233622), showed maternal PoO effects. Both ASB18 and 
AGAP1 are located within the same topologically associated domain or TAD (Figure 1). Three 
loci that exhibited the highest level of maternal PoO effects, including chr2:213801332, 
chr4:115282539 and rs10058073, are all located in intergenic regions of the human genome. 
Other interesting candidate PoO effects loci that we observed include gamma-aminobutyric acid 
(GABA) A receptor delta subunit (GABRD), hedgehog acyltransferase (HHAT), a chaperon 
protein coding gene (CCT7), DNA (cytosine-5-)-methyltransferase 3 alpha (DNMT3A), EPH 
receptor A7 (EPHA7), forkhead box O3 (FOXO3), long intergenic noncoding RNAs, amicroRNA, 
antisense RNAs and a number of genes that encode proteins zinc finger DNA-binding motifs, 
such as ZNRD1, ZFAT and ZBTB16. Within the TAD where GABRD is located is the PRMD16 
gene which has been associated with gene-environment interaction in NSCPO etiology (Yin et 
al., 2018). The SNP tagging the HHAT gene is also situated in the same TAD as both IRF6 and 
SYT14, important genes that have been associated with OFCs in both DNA sequencing studies 
and GWAS (Duan et al., 2019). We also observed an interesting hint of PoO effects within a 1 
mega base (mb) genomic region localized to the major histocompatibility complex (MHC) class I 
region on chromosome 6 (Figure 2). This region contains interesting candidate genes such as 
zinc ribbon domain containing 1 antisense, noncoding RNA (ZNRD1-AS1), major 
histocompatibility complex, class I, G (HLA-G), HLA-F antisense RNA 1 (HLA-F-AS1) 
and  tripartite motif containing group of proteins (TRIM10, TRIM26, TRIM15 and TRIM40). Most 
interestingly, all the associated loci in this genomic region exhibited maternal PoO effects. The 1 
mb MHC Class 1 locus implicated by our study is found in a TAD that harbors PBX2, a gene 
that has been associated with NSOFCs (Maili et al., 2019). 
There was no large scale evidence of genomic imprinting in our study cohort since only about 
11% of SNPs were within CpG islands (Table 2). Moreover, we observed interesting distribution 
of the suggestive paternal and maternal PoO effects on the various human chromosomes 
(Figure 3). On some of the chromosomes, the PoO effects were either solely maternal or 
paternal, whereas other chromosomes displayed missed paternal and maternal PoO effects. 
Overall, more maternal PoO effects, comprising over 58% of the associated loci, were observed 
than paternal PoO effects. 
 
Probable etiologic loci for NSOFCs that do not exhibit unidirectional PoO effects 
In situations where both P_PAT and P_MAT, as well as P_POO showed p<0.05, we considered 
this to mean over-transmission of these alleles in both parents (TDT) and may suggest probable 
loci for NSOFCs that may not exhibit unidirectional PoO effects. We observed 311 of such 
SNPs with all three p-values, P_MAT, P_PAT, AND P_POO, being less than 0.05 
(supplementary Table S1). However, Table S1 contains SNPs with overall p values of ≤1.10 × 
10-3. Interesting, as many as 9 SNPs at the 1mb genomic region localized to the MHC class I 
region on chromosome 6 once again, suggesting a potential hot spot for NSOFCs risk through 
non-unidirectional PoO effects. These SNPs included chr6:29781010, chr6:29735532, 
chr6:29737161, rs1611185, rs2735048, chr6:29834198, rs2517930, chr6:29924625 and 
chr6:29733837. These SNPs are either near or lie within introns of genes such as HLA-G, HLA-
F, HLA-F-AS1, HCG4 (Supplementary Table SI). Though these 9 SNPs exhibited both P_PAT 
and P_MAT less than 0.05, the P_MAT values were predominantly and far lower than P_PAT 
values, indicating predominant maternal over-transmission. Other interesting loci that showed 
possible association with NSOFCs but lacking unidirectional PoO effects included cadherin 10, 
type 2 [CDH10] (rs11950412 and rs75699124), solute carrier organic anion transporter family, 
member 2A1 [SLCO2A1] (chr3:133671881), lysine (K)-specific demethylase 4C [KDM4C] 
(rs818882), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, 
subfamily a, member 2 [SMARCA2] (rs111870807), PHD and ring finger domains 1 [PHRF1] 
(chr11:599653) and solute carrier family 7 (cationic amino acid transporter, y+ system), member 
1 [SLC7A1] (rs678844). 
 
DISCUSSIONS 
We carried out the first ever genome-wide scan for parent-of-origin (PoO) effects in a NSOFCs 
cohort recruited from Ghana, Ethiopia and Nigeria. The PLINK tool we used enabled us to 
perform independent tests for the maternally and paternally over-transmitted alleles (P-PAT and 
P_MAT). This approach enabled us to directly compare how the relative influences of the two 
parental genomes increase susceptibility to NSOFCs in case offsprings. We did not observe any 
genome-wide significant association in our study cohort, probable because PoO effects are 
difficult to tease out, as other relatively large scale studies could not detect statistically 
significant PoO effects in European and Asian case-parent trios (Garg et al., 2014; Duan et al., 
2017; Moreno Uribe et al., 2017). In the Garg et al (2014) study, which was a genome-wide 
analysis of about 3,700 NSOFC case parents trios, only suggestive maternal-specific and 
paternal-specific transmission biases, demonstrating PoO effects on the risk of NSOFCs, were 
observed at 8q21.3 and 2q25 (SLC4A3) loci, respectively. These three studies carried out 
subphenotype analyses for NSCPO and NSCL/P. Future studies with a larger African cohort 
may want to carry out separate analyses for these two subphenotypes of cleft. This 
notwithstanding we observed interesting hints of PoO effects in our study cohort that may 
predispose offsprings to NSOFCs. 
A SNP within the intron of ASB18 gene showed the highest significance level of P_POO = 
5.12×10-4 with overall paternal PoO effect. ASB18 encodes a protein that is a member of the 
ankyrin repeat and suppressor of cytokine signaling [SOCS] box-containing (ASB) family of 
proteins. ASB18 protein may be a substrate-recognition component of a SCF-like ECS (Elongin-
Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination 
and subsequent proteasomal degradation of target proteins (Kohroki et al., 2005). ASB18 has 
not been previously associated with OFCs or any other craniofacial anomaly, though our 
observation suggests that post-translation modification of proteins may also be a molecular 
mechanism that may influence the etiology of NSOFCs. A search through the Mouse Genome 
Informatics (MGI) database (http://www.informatics.jax.org/) showed that mutant ASB18 male 
mice have aberrant reproductive phenotypes due to abnormal meiosis resulting from Anaphase 
Bridge. Anaphase bridge occurs when telomeres of sister chromatids fuse together and is 
unable to segregate into the resultant daughter cells. Interestingly, other genes that encode 
proteins with ankyrin repeat motif, including ANKEF1 and AGAP1, also gave a hint of maternal 
PoO effects. ANKEF1 may play cardinal function in ciliated tissues and during embryonic 
development (Daniel and Panizzi, 2019) whereas AGAP1 is known to functionally interact with 
Kinesin-13 Family Member Kinesin-like Protein 2A (Kif2A), with the Kif2A-AGAP1 protein 
complex participating in the control of cytoskeleton remodeling associated with cell movement 
(Luo et al., 2016). Recently, a genome-wide scan of NSCL/P trios demonstrated PoO effects for 
similar genes with ankyrin repeat motif, such as ANK3 and ARHGEF10. The study reported 
PoO interactions between SNPs in ANK3, LYZL1, PDGFD, FOCAD and FRAS1, and maternal 
smoking, as well as between ARHGEF10 and alcohol consumption (Haaland et al., 2019). 
We also observed hints of PoO effects in genes such as GABRD, HHAT, DNMT3A, long 
intergenic noncoding RNAs, amicroRNA and antisense RNAs. Apart from GABRD, all the other 
genes products are involved in epigenetic events. GABRD encodes a protein that is a member 
of gamma-aminobutyric acid (GABA)-A receptors that are ligand-gated chloride channels whose 
chloride conductance may be modulated by agents such as benzodiazepines. The GABA-A 
receptor is generally pentameric, consisting alpha, beta, gamma, delta (GABRD) and rho 
subunits, with variants in the genes for these subunits being associated with a number of 
psychiatric disorders such as epilepsy.  In line with our observation that variants in GABRD 
exhibit paternal PoO effects, it has been demonstrated in human and mouse sperms that 
GABRD may act as progesterone receptor or modulator in spermatozoa, being responsible for 
the progesterone-induced Ca2+ influx needed for acrosome reaction by interacting with the P2X2 
receptor (Xu et al., 2017). GABRD has not previously been associated with OFCs; however, 
gamma-aminobutyric acid type A receptor subunit beta3 (GABRB3), a subunit of the GABA-A 
receptor pentamer, has been associated with cleft palate in mice 
(http://www.informatics.jax.org/marker/phenotypes/MGI:95621). For example, it has been shown 
that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) causes delayed palatal shelf elevation, 
ultimately leading to CP, by decreasing the levels of GABRB3 in mice. This implies that 
GABRB3 may play an important role in the elevation and fusion phases of the palate 
development (Lei et al., 2019). A Norwegian study could not establish association between 
NSOFCs and variants in gamma-aminobutyric acid B receptor 2 (GABBR2), a gene related to 
GABRD but associated with nicotine dependence (Jugessur et al., 2012). GABRD and other 
subunits of the GABA-A receptor pentamer is of particular interest because they demonstrate 
how the exposome can interact with the genome.  Quite recently, it was demonstrated that PoO 
effects may vary across different environmental exposures, the so–called PoOxE effects. For 
example, statistically suggestive PoO interaction effects have been shown between SNPs near 
ICE1 and NAALADL2 and maternal smoking which increases risk to NSCPO in Europeans 
(Haaland et al., 2017). HHAT encodes an enzyme that attaches palmitoyl residues crucially 
needed for multimerization as well as long- and short-range hedgehog signaling. Variants in 
HHAT have been associated with a number of craniofacial anomalies, such as cleft lip 
(Kurosaka et al., 2014) and holoprosencephaly together with acrania and agnathia in mice 
(Dennis et al., 2012), and Nivelon-Nivelon-Mabille syndrome that may present with 
microcephaly, early infantile onset seizures, and cerebellar vermis hypoplasia (Abdel-Salam et 
al., 2019). DNMT3A encodes a DNA methyltransferase that participates in de novo methylation 
but not maintenance methylation, with the expression of enzyme being developmentally 
regulated. For instance, TCDD induces global and low CpG methylation level of Dnmt3a by up-
regulating the expression of Dnmt3a which may lead to global hypermethylation in fetal palate 
tissue culminating in palate malformation (Wang et al., 2017). 
Other interesting loci that exhibited overwhelming maternal PoO effects was a 1mb genomic 
window at the MHC Class 1 locus on chromosome 6. As many as 6 SNPs demonstrated hints of 
maternal PoO effects (P_PAT>0.05, P_MAT<0.05, P_POO<0.05) at this locus which contains 
genes such as ZNRD1, ZNRD1-AS1, HLA-F, HLA-G, HLA-F AS1, TRIM26, TRIM15, TRIM10 
and TRIM40. In the other arm of the analyses that considered SNPs with all P_PAT, P_MAT 
and P_POO being <0.05, as many as 9 SNPs also showed predominantly maternal PoO 
effects. This region has not been largely associated with the etiology of OFCs, except that some 
microsatellite markers in HLA have been associated with CL/P in Indians (Rajendran et al., 
2011). Our observation possibly suggests that components of the human adaptive immune 
system at this MHC Class 1 locus on chromosome 6 may interact with maternal exposome, 
such as pathogens or allergens, to increase the risk for NSOFCs. Overall, we observed more 
probable maternal PoO effects (58% of reported SNPs) than paternal PoO effects. This is 
probably because of the high influence of the intrauterine environment and other maternal 
factors on fetal development.  
 
CONCLUSION 
The multifactorial nature of the etiology of NSOFCs warrants investigations into other genetic 
phenomena that do not exhibit classical Mendelian pattern of inheritance. Here, we conducted 
genome-wide scan for PoO effects in a sub-Saharan African cohort with NSOFCs and 
demonstrated hints of the possible existence of PoO effects that may influence risk to NSOFCs. 
Importantly, we have shown that genes that may be involved in epigenetic regulation of the 
human genome such as DNMT3A, those that serves as receptors for environmental agents 
such as GABRD and those involved in maternal immunity such as HLA-G may increase risk to 
NSOFCs through PoO effects. Further studies in larger case-parent trios, as well as 
subphenotypes analyses, are warranted in order to confirm the roles of the reported loci in the 
etiology of NSOFCs. 
 
Acknowledgment 
We greatly appreciate the families that participated in this study as well as doctors and nurses 
at the various teaching hospitals where sample collection was carried out. 
 
Declaration of Conflicting Interests 
The authors declared no potential conflicts of interest with respect to the research, authorship, 
and/or publication of this article. 
 
Funding 
The author(s) disclosed receipt of the following financial support for the research, authorship, 
and/or publication of this article: This work was supported by National Institute of Dental and 
Craniofacial Research (R00 DE022378 and R01DE028300, A.B; and K43DE029427 - L.J.J.G) 
and the Robert Wood Johnson Foundation (72429, A.B.); and the National Institutes of Health 








Abdel-Salam GMH, Mazen I, Eid M, Ewida N, Shaheen R, Alkuraya FS. Biallelic novel missense 
HHAT variant causes syndromic microcephaly and cerebellar-vermis hypoplasia. Am J Med 
Genet A. 2019; 179(6):1053-1057. 
Boyles AL, Wilcox AJ, Taylor JA, Meyer K, Fredriksen A, Ueland PM, Drevon CA, Vollset SE, 
Lie RT. Folate and One-Carbon Metabolism Gene Polymorphisms and Their Associations 
With Oral Facial Clefts. Am J Med Genet A. 2008; 146(4): 440–449. 
Butali A, Mossey PA, Adeyemo WL, Eshete MA, Gowans LJJ, Busch TD, Jain D, Yu W, Huan L, 
Laurie CA, et al. Genomic Analyses in African Populations Identify Novel Risk Loci for Cleft 
Palate. Hum Mol Genet. 2019; 28(6):1038-1051. 
Butali A, Suzuki S, Cooper ME, Mansilla AM, Cuenco K, Leslie EJ, Suzuki Y, Niimi T,  
Yamamoto M,  Ayanga G, et al.  Replication of Genome Wide Association Identified 
Candidate Genes Confirm the Role of Common and Rare Variants in PAX7 and VAX1 in the 
Etiology of Non-syndromic CL(P). Am J Med Genet A. 2013; 161(5): 965–972. 
Carlson JC, Anand D, Butali A, Buxo CJ, Christensen K, Deleyiannis F, Hecht JT, Moreno LM, 
Orioli IM, Padilla C, et al. A systematic genetic analysis and visualization of phenotypic 
heterogeneity among orofacial cleft GWAS signals. Genet. Epidemiol. 2019; 43:704–716. 
Daniel JG, Panizzi JR. Spatiotemporal expression profile of embryonic and adult ankyrin repeat 
and EF-hand domain containing protein 1-encoding genes ankef1a and ankef1b in 
zebrafish. Gene Expr Patterns. 2019; 34:119069. 
Dennis JF, Kurosaka H, Iulianella A, Pace J, Thomas N, Beckham S, Williams T, Trainor PA. 
Mutations in Hedgehog acyltransferase (Hhat) perturb Hedgehog signaling, resulting in 
severe acrania-holoprosencephaly-agnathia craniofacial defects. PLoS Genet. 2012; 
8(10):e1002927. 
Duan S-J, Huang N, Zhang B-H, Shi J-Y, He S, Ma J, Yu Q-Q, Shi B, Jia Z-L. New insights from 
GWAS for the cleft palate among han Chinese population. Med Oral Patol Oral Cir Bucal. 
2017; 22(2):e219-27. 
Garg P, Ludwig KU, Bo¨hmer AC, Rubini M, Steegers-Theunissen R, Mossey PA, Mangold E, 
Sharp AJ. Genome-wide analysis of parent-of-origin effects in non-syndromic orofacial 
clefts. Euro. J of Hum Genet. 2014; 22:822–830. 
Gjerdevik M, Haaland OA, Romanowska J, Lie RT, Jugessur A, Gjessing HK. Parent-of-origin-
environment interactions in case parent triads with or without independent controls. Ann. 
Hum. Genet. doi: 10.1111/ahg.12224. 
Haaland ØA, Jugessur A, Gjerdevik M, Romanowska J, Shi M, Beaty TH, et al. Genome-wide 
analysis of parent-of-origin interaction effects with environmental exposure (PoOxE): an 
application to European and Asian cleft palate trios. PLoS ONE 2017; 12:e0184358. 
Haaland ØA, Romanowska J, Gjerdevik M, Lie RT, Gjessing HK, Jugessur A. A genome-wide 
scan of cleft lip triads identifies parent-of-origin interaction effects between ANK3 and 
maternal smoking, and between ARHGEF10 and alcohol consumption. F1000Research 
2019; 8:960. 
Huang L, Jia Z, Shi Y, Du Q, Shi J, Wang Z, Mou Y, Wang Q, Zhang B, Wang Q, et al. (2019). 
Genetic factors define CPO and CLO subtypes of nonsyndromic orofacial cleft. PLoS Genet 
15(10): e1008357. 
Jugessur A, Wilcox AJ, Murray JC, Gjessing HK, Nguyen TT, Nilsen RM, Lie RT. Assessing the 
impact of nicotine dependence genes on the risk of facial clefts: An example of the use of 
national registry and biobank data. Nor Epidemiol. 2012; 21(2):241-250. 
Jung SH, Lee A-Y, Park JW, Baek SH, Kim YH. Investigation of Parental Transmission of 
RUNX2 Single Nucleotide Polymorphism and Its Association With Nonsyndromic Cleft Lip 
With or Without Palate. Cleft Palate–CraniofAC. J 2014; 51(2)234–239. 
Khan MFJ, Little J, Mossey PA, Steegers-Theunissen RPM, Bonsi M, Andreasi RB, Rubini M. 
Association between a common missense variant in LOXL3 gene and the risk of non-
syndromic cleft palate. Congenital Anomalies 2018; 58:136–140. 
Kohroki J1, Nishiyama T, Nakamura T, Masuho Y. ASB proteins interact with Cullin5 and Rbx2 
to form E3 ubiquitin ligase complexes. FEBS Lett. 2005; 579(30):6796-802. 
Kurosaka H, Iulianella A, Williams T, Trainor PA. Disrupting hedgehog and WNT signaling 
interactions promotes cleft lip pathogenesis. J Clin Invest. 2014; 124(4):1660-1671. 
Lawson HA, Cheverud JM, Wolf JB. Genomic imprinting and parent-of-origin effects on complex 
traits. Nat Rev Genet. 2013; 14(9): 609–617. 
Lei JQ, Qiu L, Ding XH, Fu YX, Yuan XG, Liu Y. Expression of gamma-aminobutyric acid type A 
receptor beta3 subunit in murine cleft palate induced by 2, 3, 7, 8-tetrachlorodibenzo-p-
dioxin. Zhonghua Kou Qiang Yi Xue Za Zhi. 2019; 54(5):328-334. 
Luo R, Chen PW, Wagenbach M, Jian X, Jenkins L, Wordeman L, Randazzo PA. Direct 
Functional Interaction of the Kinesin-13 Family Member Kinesin-like Protein 2A (Kif2A) and 
Arf GAP with GTP-binding Protein-like, Ankyrin Repeats and PH Domains1 (AGAP1). J Biol 
Chem. 2016; 291(41):21350-21362. 
Maili L, Letra A, Silva R, Buchanan EP, Mulliken JB, Greives MR, Teichgraeber JF, Blackwell 
SJ, Ummer R, Weber R, Chiquet B, Blanton SH, Hecht JT. PBX-WNT-P63-IRF6 pathway in 
nonsyndromic cleft lip and palate. Birth Defects Res. 2019 Dec 11. doi: 10.1002/bdr2.1630. 
[Epub ahead of print] 
Moreno Uribe LM, Fomina T, Munger RG, Romitti PA, Jenkins MM, Gjessing HK, Gjerdevik M, 
Christensen K, Wilcox AJ, Murray JC, et al. A Population-Based Study of Effects of Genetic 
Loci on Orofacial Clefts. Jf Dent. Res. 2017; 96(11):1322–1329. 
Mossey PA, Modell B. Epidemiology of oral clefts 2012: an international perspective. Front Oral 
Biol. 2012; 16:1–18. 
Nidey N, Wehby G. Barriers to health care for children with orofacial clefts: a systematic 
literature review and recommendations for research priorities. Oral Health Dent Stud. 2019; 
2(1):2. 
Nidey N, Moreno Uribe LM, Marazita MM, Wehby GL. Psychosocial well-being of parents of 
children with oral clefts. Child Care Health Dev. 2016; 42:42–50. 
Oseni GO, Deepti J, Mossey PA, Busch TD, Gowans LJJ, Eshete MA, Adeyemo WL, Laurie 
CA, Laurie CC, Owais A, et al. Identification of Paternal Uniparental Disomy on 
Chromosome 22 and a De-novo Deletion on Chromosome 18 in Individuals with Orofacial 
Clefts. Mol Genet Genomic Med. 2018; 6(6):924-932. 
Park BY, Sull JW, Park JY, Jee SH, Beaty TH. Differential Parental Transmission of Markers in 
BCL3 among Korean Cleft Case-parent Trios. J Prev Med Public Health. 2009; 42(1):1–4. 
Peters J. The role of genomic imprinting in biology and disease: an expanding view. Nat. Rev. 
Genet. 2014; 15:517–530. 
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, Sklar P, de 
Bakker PIW, Daly MJ, Sham PC. PLINK: a toolset for whole-genome association and 
population-based linkage analysis. Am. J Hum Genet. 2007; 81. 
Rajendran R, Shaikh SF, Anil S. Tracing disease gene(s) in non-syndromic clefts of orofacial 
region: HLA haplotypic linkage by analyzing the microsatellite markers: MIB, C1_2_5, 
C1_4_1, and C1_2_A. Indian J Hum Genet. 2011;17(3):188-193. 
Raju GT, Lakkakula BVKS, Murthy J, Kannan MA, Paul SFD. Transmission analysis of TGFB1 
gene polymorphisms in non-syndromic cleft lip with or without cleft palate. Int. J Ped. 
Otorhinolaryn. 2017; 100(2017):14e17. 
Reutter H, Birnbaum S, Mende M, Lauster C, Schmidt G, Henschke H, Saffar M, Martini M, 
Lauster R, Schiefke F, et al. TGFB3 displays parent-of-origin effects among central 
Europeans with nonsyndromic cleft lip and palate. J Hum Genet. 2008; 53:656–661. 
Shi M, Murray JC, Marazita ML, Munger RG, Ruczinski I, Hetmanski JB, Wu T, Murray T, 
Redett RJ, Wilcox AJ et al. Genome wide study of maternal and parent-of-origin effects on 
the etiology of orofacial clefts. Am J Med Genet A. 2012; 0(4): 784–794. 
Skare Ø, Lie RT, Haaland ØA, Gjerdevik M, Romanowska J, Gjessing HK and Jugessur A. 
Analysis of Parent-of-Origin Effects on the X Chromosome in Asian and European Orofacial 
Cleft Triads Identifies Associations with DMD, FGF13, EGFL6, and Additional Loci at 
Xp22.2. Front. Genet. 2018; 9:25. 
Suazo J, Santos JL, Jara L, Blanco R. Parent-of-origin effects for MSX1 in a Chilean population 
with nonsyndromic cleft lip/palate. Am J Med Genet Part A. 2010; 152A:2011–2016. 
Sull JW, Liang K-Y, Hetmanski JB, Fallin MD, Ingersoll RG, Park J, Wu-Chou Y-H, Chen PK, 
Chong SS, Cheah F, et al. Differential Parental Transmission of Markers in RUNX2 Among 
Cleft Case-Parent Trios From Four Populations. Genet Epidemiol. 2008; 32(6):505–512. 
Sull JW, Liang K-Y, Hetmanski JB, Wu T, Fallin MD, Ingersoll RG, Park JW, Wu-Chou Y-H, 
Chen PK, Chong SS, et al. Evidence that TGFA influences risk to cleft lip with/without cleft 
palate through unconventional genetic mechanisms. Hum Genet. 2009a; 126(3):385–394. 
Sull JW, Liang K-Y, Hetmanski JB, Fallin MD, Ingersoll RG, Park J, Wu-Chou Y-H, Chen PK, 
Chong SS, Cheah F, et al. Maternal transmission effects of the PAX genes among cleft 
case–parent trios from four populations. Euro. J Hum. Genet. 2009; 17:831–839. 
Thomas D. Gene–environment-wide association studies: emerging approaches. Nat. Rev. 
Genet. 2010; 11:259–272. 
van Rooij IALM, Ludwig KU, Welzenbach J, Ishorst N, Thonissen M, Galesloot TE, Ongkosuwito 
E, Bergé SJ, Aldhorae K, Rojas-Martinez A, et al. Non-Syndromic Cleft Lip with or without 
Cleft Palate: Genome-Wide Association Study in Europeans Identifies a Suggestive Risk 
Locus at 16p12.1 and Supports SH3PXD2A as a Clefting Susceptibility Gene. Genes 2019; 
10:1023. 
Wang C, Yuan XG, Liu CP, Zhai SN, Zhang DW, Fu YX. Preliminary research on DNA 
methylation changes during murine palatogenesis induced by TCDD. J Craniomaxillofac 
Surg. 2017; 45(5):678-684. 
Wang H, Hetmanski JB, Ruczinski I, Liang KY, Fallin MD, Redett RJ, Raymond GV, Wu-Chou 
Y-H, Chen PK-T, Yeow V, et al. ROR2 gene is associated with risk of non-syndromic cleft 
palate in an Asian population. Chin Med J (Engl). 2012; 125(3):476–480. 
Wei WH, Hemani G, Haley CS. Detecting epistasis in human complex traits. Nat. Rev. Genet. 
2014; 15:722–733. 
Wu D, Wang M, Wang X, Yin N, Song T, Li H, Zhang F, Zhang H, Ye Z, Yu J, et al. Maternal 
Transmission Effect of a PDGF-C SNP on Nonsyndromic Cleft Lip with or without Palate 
from a Chinese Population. PLoS ONE 2012; 7(9):e46477. 
Xu W, Wang K, Chen Y, Liang XT, Yu MK, Yue H, Tierney ML. Sperm gamma-aminobutyric 
acid type A receptor delta subunit (GABRD) and its interaction with purinergic P2X2 
receptors in progesterone-induced acrosome reaction and male fertility. Reprod Fertil Dev. 
2017; 29(10):2060-2072. 
Yin B, Shi B, Jia ZL. Associations among PRDM16 polymorphisms, environmental exposure 
factors during mother's pregnancy, and nonsyndromic cleft lip with or without cleft palate. 
Hua Xi Kou Qiang Yi Xue Za Zhi. 2018; 36(5):503-507. 
Zeng Y, Amador C, Xia C, Marioni R, Sproul D, Walker RM, Morris SW, Bretherick A, Canela-
Xandri O, Boutin TS, et al. Parent of origin genetic effects on methylation in humans are 
common and influence complex trait variation. Nature Comm. 2019; 10:1383. 
 
